| Literature DB >> 25888230 |
Zoran Trogrlić1, Mathieu van der Jagt2, Jan Bakker3, Michele C Balas4, E Wesley Ely5,6, Peter H J van der Voort7, Erwin Ista8.
Abstract
INTRODUCTION: Despite recommendations from professional societies and patient safety organizations, the majority of ICU patients worldwide are not routinely monitored for delirium, thus preventing timely prevention and management. The purpose of this systematic review is to summarize what types of implementation strategies have been tested to improve ICU clinicians' ability to effectively assess, prevent and treat delirium and to evaluate the effect of these strategies on clinical outcomes.Entities:
Mesh:
Year: 2015 PMID: 25888230 PMCID: PMC4428250 DOI: 10.1186/s13054-015-0886-9
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Implementation strategy taxonomy according to the EPOC classification system
|
|
|
|
|---|---|---|
| Professional | 1. Distribution of educational materials | Distribution of published or printed recommendations for clinical care, including clinical practice guidelines, audio-visual materials and electronic publications. The materials may have been delivered personally or through mass mailings. |
| 2. Educational meetings | Conferences, lectures, workshops or traineeships. | |
| 3. Local consensus processes | Inclusion of participating providers in discussion to ensure that they agreed that the chosen clinical problem was important and the approach to managing the problem was appropriate. | |
| 4. Outreach visits | Use of a trained person who met with providers in their practice settings to give information with the intent of changing the provider’s practice. The information given may have included feedback on the performance of the provider(s). | |
| 5. Local opinion leader | Use of providers nominated and explicitly identified by their colleagues as educationally influential. | |
| 6. Patient-mediated intervention | New, previously unavailable clinical information collected directly from patients and given to the provider; for example, patient depression scores from a survey instrument. | |
| 7. Audit and feedback | Any summary of clinical performance of health care over a specified period of time. The summary may also have included recommendations for clinical action. The information may have been obtained from medical records, computerized databases, or observations from patients. | |
| 8. Reminders | Patient or encounter-specific information, provided verbally, on paper or on a computer screen, which is designed or intended to prompt a health professional to recall information. This would usually be encountered through their general education; in the medical records or through interactions with peers, and so remind them to perform or avoid some action to aid individual patient care. Computer-aided decision support and drugs dosage are included. | |
| 9. Marketing / Tailored interventions | Use of personal interviewing, group discussion (focus groups), or a survey of targeted providers to identify barriers to change and subsequent design of an intervention that addresses identified barriers. | |
| 10. Mass media | (1) Varied use of communication that reached great numbers of people including television, radio, newspapers, posters, leaflets, and booklets, alone or in conjunction with other interventions; (2) targeted at the population level. | |
| Organizational | 11. Provider oriented interventions | Revision of professional roles, for example, expansion of role to include new tasks; creation of clinical multidisciplinary teams who work together; formal integration of services; skill mix changes (changes in numbers, types or qualifications of staff); arrangements for follow up; satisfaction of providers with the conditions of work and the material and psychic rewards (for example, interventions to boost morale); communication and case discussion between distant health professionals |
| 12. Patient oriented interventions | Mail order pharmacies (for example, compared to traditional pharmacies); presence and functioning of adequate mechanisms for dealing with patients’ suggestions and complaints; consumer participation in governance of health care organization; other categories | |
| 13. Structural interventions | Changes to the setting/site of service delivery; changes in physical structure, facilities and equipment; changes in medical records systems (for example, changing from paper to computerized records); changes in scope and nature of benefits and services; presence and organization of quality monitoring mechanisms; ownership, accreditation, and affiliation status of hospitals and other facilities; staff organization | |
| Financial | 14. Provider or patient interventions | In summary: patient or provider is financially supported to execute specific actions. For detailed definitions, see reference [ |
| Regulatory | 15. Changes in medical liability | Any intervention that aims to change health services delivery or costs by regulation or law (these interventions may overlap with organizational and financial interventions). |
| 16. Management of patient complaints | ||
| 17. Peer review or Licensure |
EPOC, Cochrane Effective Practice and Organisation of Care group.
Figure 1Selection of included studies for the review.
Summary of implementation strategies
|
|
|
|
| |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
| 1 | Distribution** | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 81 |
| 2 | Educational Meetings | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 100 | |
| 3 | Local consensus | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 62 | |
| 4 | Outreach | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 67 | |
| 5 | Opinion leaders | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 52 | |
| 6 | Patient-mediated | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 86 | |
| 7 | Audit/feedback | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 62 | |
| 8 | Reminders | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 38 | |
| 9 | Tailoring (barriers) | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 33 | |
| 10 | Mass media | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
|
| 11 | Provider-oriented | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 43 |
| 12 | Patient-oriented | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 13 | Structural | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 48 | |
|
| 14 | Provider | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10 |
|
| 15 | Medical liability | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 16 | Patient complaints | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17 | peer review/licensure | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
| ||||||||||||||||||||||||
|
|
| ⬇ | ⬇ | ↓ | ↓ | ↓ | ↑ | = | ↓ | ↑ | - | - | - | - | - | - | - | - | - | - | - | |||
|
| ⬇ | ⬇ | ↓ | ⬇ | ↓ | ↓ | = | ⬇ | ⬇ | = | - | - | - | - | - | ↓ | - | - | - | - | - | |||
|
| ⬆ | ↑ | ⬆ | ⬆ | - | - | - | ⬆ | - | - | ⬆ | ⬆ | - | ⬆ | ⬆ | ⬆ | ⬆ | = | ⬆ | ⬆ | ⬆ | |||
|
| - | ↓ | ⬇ | - | - | ⬇ | ⬇ | ⬇ | ↑ | - | - | - | - | - | ↑ | ⬆ | - | ⬆ | - | - | - | |||
|
| ↓ | ↑ | ↑ | - | ↑ | - | - | ⬇ | ↓ | ⬇ | - | - | - | - | - | ⬇ | - | - | - | - | - | |||
|
| - | - | - | - | - | - | - | - | - | - | - | ⬆ | ⬆ | ⬆ | - | ⬆ | - | - | - | - | - | |||
*Study by Eastwood concerns the same study population as the study by Reade and was therefore not used for analysis of clinical outcomes. **For explanation of individual strategies, see Table 1.
***Only statistically significant changes are in bold text. PO, professional-oriented; O, organizational; F, financial; R, regulatory; IS, implementation strategies.
Implementation characteristics and changes in important process and clinical outcomes before versus after implementation
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |
| Balas, 2014 [ | 12 | ABCDEb | CFIRc |
|
| +12 mg (6 to 18 mg)e, | - |
|
|
| Van den Boogaard, 2009 [ | 12 | Delirium screening | Model of Grol and Wensing |
|
|
|
|
|
|
| Riekerk, 2009 [ | 10 | Delirium screening | Structural implementation pathway |
|
|
|
|
|
|
| Hager, 2013 [ | 10 | PADw | 4Es frameworki | 0 (90 to 90%) |
|
| - |
|
|
| Skrobik, 2010 [ | 9 | PAD | - | +3k (89 to 92%), | −0.5% (34.7 to 34.2%), | +0.3% (39.4 to 39.7%), | - |
|
|
| Bowen, 2012 [ | 8 | Delirium screening | Diffusion of Innovations theory |
|
|
| - |
|
|
| Soja, 2008 [ | 10 | Delirium screening | - |
| - | - | - |
|
|
| Gesin, 2012 [ | 7 | Delirium screening | - | - |
|
|
|
|
|
| Mansouri, 2013 [ | 7 | PAD | - |
| - | −2.5 mgn (3.2 to 0.7 mg), | - |
|
|
| Pun, 2005 [ | 6 | PAD | - |
|
| - | - |
|
|
| Radtke, 2012 [ | 7 | PAD | Modified extended training |
| - | - | - | −4.8%o (9.9 to 5.1%), | −4 (18 to 14)p, |
|
| |||||||||
| Eastwood, 2012 [ | 4 | Delirium screening | - |
| - |
| - | +3.2% (5 to 8.2)s,t
| 0 (2 to 2), |
| Kamdar, 2013 [ | 6 | Multifaceted sleep promotion program | Structured QI model | - |
|
| - | −6% (25 to 19%), | −1.1u (5.4 to 4.3), |
| Scott, 2012 [ | 4 | Delirium screening | - |
|
|
|
|
|
|
| Dale, 2014 [ | 5 | PAD | - |
|
|
| - | 0 (14 to 14%), |
|
| Kastrup, 2011 [ | 7 | Visual feedback system | - |
| +4% (25 to 29%), |
| - |
|
|
| Robinson, 2008 [ | 5 | PAD | - | - | - | +14% (31 to 45%), | - | −2.9% (17.6 to 14.7), | −1.8 (5.9 to 4.1), |
| Devlin, 2008 [ | 6 | Delirium screening | SCTzb |
| - |
| - | - | - |
| Page, 2009 [ | 4 | Delirium screening | - |
|
| - | - | - | - |
| Reade, 2011 [ | 4 | Delirium screening | - | - |
|
| - | +3.2% (5 to 8.2)zc, | 0 (2 to 2), |
| Bryczkowski, 2014 [ | 3 | Delirium prevention program | - | - | +11% (58 to 47%), | −1% (7 to 6%), | - | −4% (7 to 3%), |
|
aB/A = before-after. bABCDE = awakening and breathing coordination, delirium monitoring/management and early exercise/mobilization bundle. cCFIR = Consolidated Framework for Implementation Research. dStatistical significance not reported or assessable from data in article but presumed to be statistically significant because of strong effect (difference before-after shown in parentheses). Significant changes are shown in bold letters. eTotal dose of haloperidol per patient. fMedian. gChi-square test. hIncrease in median level of agreement on a scale of 5 (1 = totally disagree, 5 = totally agree, with 3 = neutral about statement and 4 = agree) with true statements about delirium, signifying increased knowledge. i4Es framework = Engage, Educate, Execute and Evaluate. jPercent of ICU days delirium present per patient. kAdherence calculated by dividing delirium assessments judged to be possible by total number of patients in Table 1 in reference. Adherence data to screening not explicitly provided in text. lMean. mNo explicit mention of screening adherence, but after CAM-ICU implementation as part of the PAD guideline the authors mention strict adherence surveillance to the PAD protocol: 15 patients in protocol group excluded from analysis because of noncompliance with PAD guideline. nMean dose of drug (haloperidol) used per patient. oMortality calculated from numbers given in Table 1 in original article for combined data of ICU 1 and 2 (n = 131, before-after comparison made with chi-squared test, degrees of freedom (df) = 2). pThis study reported different interventions (standard training versus extended training and implementation) in different ICUs. Numbers given here are those from the B/A study in two ICUs that received modified extended training. qPercentage is total number of administered doses of either haloperidol (5 mg), olanzapine (5 to 10 mg) or quetiapine (25 mg) divided by the total number of 8-hour shifts in pre- and post-CAM-ICU implementation period. Study of Eastwood is duplicate report of study by Reade, therefore, data were combined for analysis. rChi-squared statistic = 47, df = 1. sUnstructured delirium screening versus CAM-ICU screening. tData on change in mortality were not included for analysis of all mortality data because these data are same as those of Reade, 2011 [35]. uCalculated for survivors, median, frequency of delirium monitoring per day per patient. vCalculated agreement with true statements about delirium and its importance increased with 14% after the implementation, signifying increased knowledge (chi-squared statistic = 14, df = 1). wPAD = integrated pain, agitation/sedation and delirium monitoring and management; xNumber of CAM-ICU assessments/day (mean). yMean daily haloperidol dose (mg). zaFisher’s exact test. zbSCT = script concordance theory. zcPercent patients ever receiving haloperidol.
Figure 2Pooled analysis of determinants of changes in ICU length of stay (days) in implementation studies (n = 7) that included delirium-oriented interventions. Determinants of ICU length of stay reduction that were studied were: use of either the guideline for the management of pain, agitation and delirium (PAD) or the awakening and breathing coordination, choice of sedative, delirium monitoring and management and early mobility (ABCDE) bundle (a) or use of high or low number of implementation strategies (b). (c) Impact of high or low number of strategies within the studies reporting ICU length of stay and using PAD/ABCDE (n = 4). See text for more details. Study by Radtke reported multiple populations and these were separately assessed.
Figure 3Pooled analysis of determinants of changes in mortality (risk ratio) in implementation studies (n = 9) that included delirium-oriented interventions. Determinants of mortality reduction that were studied were: use of either the guideline for the management of pain, agitation and delirium (PAD) or the awakening and breathing coordination, choice of sedative, delirium monitoring and management and early mobility (ABCDE) bundle (a) or use of high or low number of implementation strategies (b). (c) Impact of high or low number of strategies within the studies reporting mortality and using PAD/ABCDE (n = 6). See text for more details.